AI system shows high accuracy for diabetic retinopathy screening
Top Institutions in Ophthalmology and Artificial Intelligence in Diabetic Retinopathy Screening
Leading institutions combine expertise in ophthalmology, diabetes research, and AI technology development to validate automated retinal image analysis systems through clinical trials and real-world implementation studies, ensuring high diagnostic accuracy and operational feasibility.
-
#100
Massachusetts Institute of Technology (MIT) - Computer Science and Artificial Intelligence Laboratory (CSAIL)
Cambridge, MA
MIT CSAIL leads in developing advanced AI algorithms for medical image analysis, including diabetic retinopathy screening, with strong collaborations with clinical partners to validate AI systems in real-world settings.
Key Differentiators
- Artificial Intelligence
- Ophthalmology
- Medical Imaging
-
#89
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins integrates clinical ophthalmology expertise with AI research to develop and implement automated diabetic retinopathy screening tools, emphasizing translational research and patient outcomes.
Key Differentiators
- Ophthalmology
- Endocrinology
- Artificial Intelligence
-
#85
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is recognized for pioneering AI applications in ophthalmology, including diabetic retinopathy screening, with extensive clinical datasets and multidisciplinary teams advancing AI integration into routine care.
Key Differentiators
- Ophthalmology
- Artificial Intelligence
- Diabetes Research
-
#80
Université Libre de Bruxelles (ULB) - Center for Diabetes Research
Brussels, Brussels-Capital Region
ULB combines diabetes clinical care with AI research, demonstrated by recent studies validating AI systems for diabetic retinopathy screening in endocrinology clinics, emphasizing real-world applicability and operational feasibility.
Key Differentiators
- Diabetes Research
- Ophthalmology
- Artificial Intelligence
-
#78
Stanford University School of Medicine
Stanford, CA
Stanford leads in AI-driven ophthalmic research with robust programs developing and clinically validating automated diabetic retinopathy detection systems, supported by large-scale datasets and interdisciplinary collaboration.
Key Differentiators
- Ophthalmology
- Artificial Intelligence
- Biomedical Informatics
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.